Digital Pharma Program

The courses in this program:

explore how digital transformation and emerging information technologies (especially Agentic AI, blockchain, and security) foster innovation, particularly by leveraging technology to achieve a competitive edge in the pharmaceutical/life sciences industry.

are customized based on the specific pharmaceutical industry (e.g., Research and Development (R&D) Companies, Generic Drug Manufacturers, Biotechnology Companies, Large Multinational Pharmaceutical Companies (“Big Pharma”), Specialty Pharmaceutical Companies, Contract Research Organizations (CROs), Over-the-Counter (OTC) Drug Manufacturers, Vaccine Manufacturers), and the backgrounds and objectives of the candidates.

This 4-course customized program (described below) prepares IT professionals and non-IT executives to lead at the intersection of pharma and technology. Participants will learn to:

Align business-IT strategy with pharmaceutical industry trends, agile portfolio management, and GxP/FDA regulatory governance
Apply generative AI, real-world evidence, and decentralized clinical trials to accelerate new drug development
Build resilient, compliant pharmaceutical supply chains through Pharma 4.0 automation, IoT cold-chain monitoring, and DSCSA compliance
Design compliant, data-driven commercial strategies using CRM, AI-driven HCP targeting, and patient engagement platforms
Govern pharma IT investment, manage regulatory risk (GxP, FDA CSA, DSCSA, HIPAA), and measure ROI across R&D and commercial systems

Select at least 4 courses from the following:

(All courses are available live/synchronously face-to-face & online)

1. Pharmaceutical Industry Trends and Issues

The pharmaceutical industry operates at the complex intersection of rapid scientific innovation, strict global regulations, and evolving market dynamics. Designed for technology and business leaders, this course provides a comprehensive analysis of the commercial, regulatory, and digital forces shaping modern life sciences. Participants will evaluate how digital transformation enables competitive advantage—examining business-IT strategy alignment, emerging IT service provider models, agile portfolio management, and modern digital governance across global pharma enterprises, especially in light of Agentic AI.

Key Focus Areas: Life Sciences Macro Trends; Business-IT Alignment Strategy; Agile IT Portfolio Management; Emerging Vendor & Sourcing Models; Regulatory Compliance Governance (GxP, FDA); Digital Transformation Leadership.

2. Pharmaceutical Industry New Drug Development

Accelerating time-to-market for novel therapeutics requires a complete modernization of the research and development lifecycle. This course examines how technology transforms drug discovery, pre-clinical research, and clinical trials. R&D and technology leaders will explore how to integrate Generative AI in molecule design, leverage Real-World Data (RWD) and Real-World Evidence (RWE), Agentic AI for regulatory submission drafting across the R&D pipeline, deploy decentralized clinical trial (DCT) platforms, and streamline regulatory submissions through modern data integration frameworks.

Key Focus Areas: AI-Driven Drug Discovery & Target Identification; Real-World Evidence (RWE) Analytics; Decentralized & Hybrid Clinical Trials; Electronic Data Capture (EDC) & Clinical Data Management; FDA Computer Software Assurance (CSA); Cross-Ecosystem Research Collaboration.

3. Pharmaceutical Industry Supply Chain

Maintaining global supply chain integrity and operational resilience is critical for pharmaceutical organizations. This course addresses how to build end-to-end visible, compliant, and agile pharmaceutical supply networks. Participants will evaluate digital manufacturing strategies (Pharma 4.0), automated cold-chain monitoring via IoT, predictive demand forecasting, and compliance with global serialization mandates such as the Drug Supply Chain Security Act (DSCSA).

Key Focus Areas: DSCSA & Global Track-and-Trace Compliance; Pharma 4.0 & Smart Factory Automation; IoT Cold-Chain & Temperature Monitoring; Predictive Demand Planning; Supplier Risk Management; Cloud-Based Supply Chain Analytics.

4. Pharmaceutical Marketing and Sales

The commercial function in pharmaceuticals is shifting from traditional sales models to personalized, data-driven, omnichannel healthcare engagement. This course focuses on the strategy, technologies, and governance required to lead modern pharma commercial operations. Marketing, sales, and IT executives will learn to leverage customer relationship management (CRM) platforms, AI-driven (Agentic AI) HCP (Healthcare Professional) targeting, patient engagement portals, and advanced commercial analytics while remaining fully compliant with strict marketing regulations.

Key Focus Areas: Omnichannel HCP & Patient Engagement; AI-Driven Commercial Analytics & Next-Best-Action Engine; Cloud-Based Pharma CRM & Sales Enablement; Digital Marketing Compliance & Medical/Legal/Regulatory (MLR) Review Workflows; Data Privacy & Consent Management.

5. IT Applications for Pharmaceutical/Bio Tech

Biotechnology, specialty pharma, and medical device organizations rely on specialized enterprise application suites to drive operational compliance and efficiency. This course evaluates the selection, integration, and management of core software architectures tailored for life sciences. Participants will examine Enterprise Resource Planning (ERP), Quality Management Systems (QMS), Laboratory Information Management Systems (LIMS), and Regulatory Information Management (RIM)—focusing on cloud migration, system validation, and multi-cloud security.

Key Focus Areas: Life Sciences ERP, QMS, LIMS, and RIM Architecture; Cloud Migration & GxP Validation; Interoperability & Enterprise System Integration; Cybersecurity (Multi-Cloud Governance (cross-provider validation, data residency for GxP systems) and Zero Trust access controls for ERP/QMS/LIMS/RIM platforms) & Ransomware Resilience; Data Integrity & ALCOA+ Principles.

6. Patient-Centric Medicine

Advances in continuous biometrics, remote monitoring, and personalized therapeutics are redefining the relationship between pharmaceutical brands, providers, and patients. This course explores the technology architectures and commercial strategies required to deliver patient-centric solutions. Participants will evaluate Digital Therapeutics (DTx), companion apps, medication adherence platforms, and patient-generated health data (PGHD) integration—aligning consumer technology with clinical value and reimbursement frameworks.

Key Focus Areas: Digital Therapeutics (DTx) & Companion Software; Remote Patient Monitoring (RPM) & Wearables; Medication Adherence & Behavioral Analytics; Patient Data Privacy & Consent Architectures; Value-Based Care Alignment.

As pharmaceutical and biotech organizations accelerate digital transformation across R&D, manufacturing, supply chains, and commercial operations, strategic investment in technology is no longer an operational expense—it is a primary driver of competitive advantage and drug pipeline velocity. Operating within a heavily regulated, resource-constrained, and cost-conscious global market requires senior leaders to efficiently govern Health IT resources while building seamless cross-functional alignment between R&D, Commercial, Operations, and Technology executives.

Designed specifically for senior pharmaceutical executives, this course provides the strategic frameworks, governance models, and decision-making tools necessary to lead high-impact digital initiatives. Participants will evaluate how to establish decision rights, optimize technology portfolios, manage regulatory risk, and leverage disruptive innovations—from Generative AI to smart supply chain automation—to drive sustainable enterprise value.

Program Overview

Format: Live / Synchronous (In-Person or Online)
Duration: 20 Contact Hours (Flexible delivery, typically ten 2-hour sessions)
Target Audience: C-Suite Executives (CEO, CIO, CTO, Chief Scientific Officer, Chief Commercial Officer, CFO), VPs, General Managers, and Senior Directors across Pharma, Biotech, and Life Sciences

Key Executive Focus Areas

Strategic Business & Pipeline Alignment: Formulate cohesive digital strategies that directly accelerate drug discovery, optimize clinical trial execution, and streamline commercial launch models.
Governance, Structure, & Decision Rights: Establish robust governance frameworks, organizational structures, sourcing strategies, and clear accountability models for enterprise technology investments.
Emerging Digital Technologies in Life Sciences: Evaluate the strategic and operational impact of Generative AI/LLMs (especially Agentic AI and Zero Trust) in R&D, automated GxP processes, real-world data (RWD) analytics, and modern cloud architectures.
Smart Supply Chain & Operational Resilience: Address the digital transformation of pharmaceutical manufacturing and distribution (Pharma 4.0), including IoT cold-chain tracking, predictive demand forecasting, and serialization compliance.
Cyber Resilience & Regulatory Governance: Navigate complex global compliance landscapes (GxP, FDA CSA, DSCSA, HIPAA) while building multi-cloud security and ransomware defenses to protect intellectual property.
Measuring & Maximizing Pharma IT Value: Implement executive frameworks to evaluate Total Cost of Ownership (TCO), measure return on investment (ROI) across R&D and commercial systems, and ensure capital optimization.
Cross-Executive Leadership & Alignment: Foster collaborative, cross-functional partnerships between technical, scientific, and commercial leadership to successfully drive organizational change.